[[Translated article]]Nadolol for Infantile Hemangiomas Previously Treated with Propranolol
Actas Dermosifiliogr. 2023 Dec 2:S0001-7310(23)00957-2. doi: 10.1016/j.ad.2023.11.015. Online ahead of print.NO ABSTRACTPMID:38048940 | DOI:10.1016/j.ad.2023.11.015 (Source: Actas Dermo-Sifiliograficas)
Source: Actas Dermo-Sifiliograficas - December 4, 2023 Category: Dermatology Authors: M Colmenero Sendra J Del Boz Gonz ález J M Segura Palacios I Valladares Mill án M Eguiluz Solana M De Troya Mart ín Source Type: research
[[Translated article]]Nadolol for Infantile Hemangiomas Previously Treated with Propranolol
Actas Dermosifiliogr. 2023 Dec 2:S0001-7310(23)00957-2. doi: 10.1016/j.ad.2023.11.015. Online ahead of print.NO ABSTRACTPMID:38048940 | DOI:10.1016/j.ad.2023.11.015 (Source: Actas Dermo-Sifiliograficas)
Source: Actas Dermo-Sifiliograficas - December 4, 2023 Category: Dermatology Authors: M Colmenero Sendra J Del Boz Gonz ález J M Segura Palacios I Valladares Mill án M Eguiluz Solana M De Troya Mart ín Source Type: research
Green tea and nadolol interaction: A risk of therapeutic inefficiency, a case report and extensive review
Therapie. 2023 Oct 19:S0040-5957(23)00144-0. doi: 10.1016/j.therap.2023.10.002. Online ahead of print.NO ABSTRACTPMID:37951784 | DOI:10.1016/j.therap.2023.10.002 (Source: Therapie)
Source: Therapie - November 11, 2023 Category: Psychiatry & Psychology Authors: Anthony Facile Antoine Deliniere Marine Auffret Thierry Vial Antony Citterio-Quentin Philippe Chevalier Guillaume Grenet Source Type: research
Green tea and nadolol interaction: A risk of therapeutic inefficiency, a case report and extensive review
Therapie. 2023 Oct 19:S0040-5957(23)00144-0. doi: 10.1016/j.therap.2023.10.002. Online ahead of print.NO ABSTRACTPMID:37951784 | DOI:10.1016/j.therap.2023.10.002 (Source: Therapie)
Source: Therapie - November 11, 2023 Category: Psychiatry & Psychology Authors: Anthony Facile Antoine Deliniere Marine Auffret Thierry Vial Antony Citterio-Quentin Philippe Chevalier Guillaume Grenet Source Type: research
Green tea and nadolol interaction: A risk of therapeutic inefficiency, a case report and extensive review
Therapie. 2023 Oct 19:S0040-5957(23)00144-0. doi: 10.1016/j.therap.2023.10.002. Online ahead of print.NO ABSTRACTPMID:37951784 | DOI:10.1016/j.therap.2023.10.002 (Source: Therapie)
Source: Therapie - November 11, 2023 Category: Psychiatry & Psychology Authors: Anthony Facile Antoine Deliniere Marine Auffret Thierry Vial Antony Citterio-Quentin Philippe Chevalier Guillaume Grenet Source Type: research
Autosomal Recessive Long QT Syndrome: Clinical Aspects and Therapy
AbstractThe autosomal recessive (AR) form of Long QT Syndrome (LQTS) is described both associated with deafness known as Jervell and Lange-Nielsen (JLN) syndrome, and without deafness (WD). The aim of the study is to report the characteristics of AR LQTS patients and the efficacy of the therapy. Data of all children with AR LQTS referred to the Bambino Ges ù Children’s Hospital IRCCS from September 2012 to September 2021were included. Three (30%) patients had compound heterozygosity and 7 (70%) had homozygous variants of theKCNQ1 gene, the latter showing deafness. Four patients (40%) presented aborted sudden cardiac dea...
Source: Pediatric Cardiology - September 26, 2023 Category: Cardiology Source Type: research
Autosomal Recessive Long QT Syndrome: Clinical Aspects and Therapy
AbstractThe autosomal recessive (AR) form of Long QT Syndrome (LQTS) is described both associated with deafness known as Jervell and Lange-Nielsen (JLN) syndrome, and without deafness (WD). The aim of the study is to report the characteristics of AR LQTS patients and the efficacy of the therapy. Data of all children with AR LQTS referred to the Bambino Ges ù Children’s Hospital IRCCS from September 2012 to September 2021were included. Three (30%) patients had compound heterozygosity and 7 (70%) had homozygous variants of theKCNQ1 gene, the latter showing deafness. Four patients (40%) presented aborted sudden cardiac dea...
Source: Mammalian Genome - September 26, 2023 Category: Genetics & Stem Cells Source Type: research
Ivabradine as a treatment option for junctional ectopic tachycardia in an adult female
AbstractA Junctional ectopic tachycardia diagnosis was performed using two electrophysiological maneuvers in an adult female with a narrow-complex supraventricular tachycardia with a bystander AV-node slow pathway conduction, who previously underwent catheter ablation attempts for an atrio-ventricular nodal re-entrant tachycardia misdiagnosis. The first maneuver was atrial entrainment with an atrial-His-His-atrial response. The second was based on the response to a premature atrial complex delivered at different phases of the tachycardia cycle confirming that anterograde slow pathway conduction and retrograde fast pathway ...
Source: Pacing and Clinical Electrophysiology : PACE - August 31, 2023 Category: Cardiology Authors: Enrico Baldi,
Antonio Sanzo,
Simone Savastano,
Roberto Rordorf Tags: CASE REPORT Source Type: research
Non-selective beta-blockers and the incidence of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis
Conclusion: Different types of NSBB have different effects on the incidence of patients with cirrhosis of the liver, where nadolol and carvedilol can reduce the risk. Also, the effect of NSBBs may vary in ethnicity. Propranolol can reduce HCC incidence in Europe and America.Systematic Review Registration: identifier https://CRD42023434175, https://www.crd.york.ac.uk/PROSPERO/. (Source: Frontiers in Pharmacology)
Source: Frontiers in Pharmacology - July 19, 2023 Category: Drugs & Pharmacology Source Type: research
An Update on Impacts of Epigallocatechin Gallate Co-administration in Modulating Pharmacokinetics of Statins, Calcium Channel Blockers, and Beta-blockers
Planta Med DOI: 10.1055/a-2111-7319Brewed green tea, green tea extract, and its primary active compound, epigallocatechin gallate, may interact with drugs and alter the drugʼs therapeutic effectiveness, ultimately leading to
therapeutic failure or drug overdose. Several isolated reports have claimed that epigallocatechin gallate is the main active ingredient that causes these effects. While a few studies aimed
to uncover evidence of epigallocatechin gallate-drug interactions, no study has thoroughly and collectively reviewed them. Epigallocatechin gallate is a potential cardioprotective agent used
by many p...
Source: Planta Medica - July 14, 2023 Category: Drugs & Pharmacology Authors: Siew-Keah, Lee Jie, Tan Hong Ang-Lim, Chua Bin, Liew Kai Yik-Ling, Chew Tags: Reviews Source Type: research
Inpatient Management of Decompensated Cirrhosis
In this clinical-pearl-packed session, Dr. Suchita Shah Sata from Duke University Hospital in Durham, N.C., recaps the breadth of knowledge needed by hospitalists to manage this complex patient population. Outlining the objectives of the talk, Dr. Sata describes the pathophysiology of cirrhosis and how this leads to the complications that are seen in the decompensated state, suggests a framework for evaluating the etiologies of decompensated cirrhosis, and applies current evidence to delineate best practices in inpatient management of common complications of cirrhosis.
Reviewing the pathophysiology of decompensated cirrhos...
Source: The Hospitalist - July 5, 2023 Category: Hospital Management Authors: Ronda Whitaker Tags: Clinical Guidelines Liver Disease Source Type: research
Nadolol/octreotide
(Source: Reactions Weekly)
Source: Reactions Weekly - July 1, 2023 Category: Drugs & Pharmacology Source Type: research
Nadolol for Infantile Hemangiomas Previously Treated With Propranolol
Actas Dermosifiliogr. 2023 Jun 23:S0001-7310(23)00522-7. doi: 10.1016/j.ad.2023.05.025. Online ahead of print.NO ABSTRACTPMID:37356545 | DOI:10.1016/j.ad.2023.05.025 (Source: Actas Dermo-Sifiliograficas)
Source: Actas Dermo-Sifiliograficas - June 25, 2023 Category: Dermatology Authors: M Colmenero Sendra J Del Boz Gonz ález J M Segura Palacios I Valladares Mill án M Eguiluz Solana M De Troya Mart ín Source Type: research
Nadolol for Infantile Hemangiomas Previously Treated With Propranolol
Actas Dermosifiliogr. 2023 Jun 23:S0001-7310(23)00522-7. doi: 10.1016/j.ad.2023.05.025. Online ahead of print.NO ABSTRACTPMID:37356545 | DOI:10.1016/j.ad.2023.05.025 (Source: Actas Dermo-Sifiliograficas)
Source: Actas Dermo-Sifiliograficas - June 25, 2023 Category: Dermatology Authors: M Colmenero Sendra J Del Boz Gonz ález J M Segura Palacios I Valladares Mill án M Eguiluz Solana M De Troya Mart ín Source Type: research
Po-01-134 an international multicenter cohort study on beta-blocker free treatment strategies for catecholaminergic polymorphic ventricular tachycardia
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare potentially life-threatening genetic heart disease. Non-selective beta-blockers (BBs, namely nadolol and propranolol) are highly effective in reducing CPVT-triggered arrhythmic events. However, some patients suffer from unacceptable BB side effects and might require BB-free treatment strategies that include flecainide, left cardiac sympathetic denervation (LCSD), combination therapy, or potentially even intentional non-therapy (INT) as has been published for long QT syndrome. (Source: Heart Rhythm)
Source: Heart Rhythm - May 1, 2023 Category: Cardiology Authors: Raquel A. Neves, Sahej Bains, Johan M. Bos, Christian van der Werf, Auke Bergeman, Puck Peltenburg, Shubhayan Sanatani, Heikki Swan, VINCENT PROBST, Prince J. Kannankeril, Jonathan R. Skinner, Ramon Brugada, Tomas Robyns, Martin M. Borggrefe, Wataru Shimi Source Type: research
